FDA Import Refusal AEK-7960317-9/30003/1 — D.M. Pharma
The FDA refused shipment AEK-7960317-9/30003/1 from D.M. Pharma (India) on Nov 24, 2025. The refused product falls under Drugs and Biologics — REPAGLINIDE (ANTI-DIABETIC). Cited charges: 118,3280 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Nov 24, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY56 REPAGLINIDE (ANTI-DIABETIC)
- Charges
- 118,3280